Patient characteristics
| Characteristic . | Value . |
|---|---|
| No. of patients | 172 (100%) |
| Male | 95 (55.2%) |
| Female | 77 (44.8%) |
| Median age, y (range) | 54 (18-83) |
| < 60 y | 104 (60.5%) |
| ≥ 60 y | 68 (39.5%) |
| ≥ 70 y | 20 (11.6%) |
| Induction per protocol | 168 (97.6%) |
| ECOG performance status (n = 141) | |
| 0 | 50 (35%) |
| 1 | 68 (48%) |
| 2 | 21 (15%) |
| 3 | 2 (1%) |
| Cytogenetic subgroup (n = 151) | |
| Favorable | 14 (9%) |
| Intermediate | 104 (69%) |
| Unfavorable | 33 (22%) |
| Characteristic . | Value . |
|---|---|
| No. of patients | 172 (100%) |
| Male | 95 (55.2%) |
| Female | 77 (44.8%) |
| Median age, y (range) | 54 (18-83) |
| < 60 y | 104 (60.5%) |
| ≥ 60 y | 68 (39.5%) |
| ≥ 70 y | 20 (11.6%) |
| Induction per protocol | 168 (97.6%) |
| ECOG performance status (n = 141) | |
| 0 | 50 (35%) |
| 1 | 68 (48%) |
| 2 | 21 (15%) |
| 3 | 2 (1%) |
| Cytogenetic subgroup (n = 151) | |
| Favorable | 14 (9%) |
| Intermediate | 104 (69%) |
| Unfavorable | 33 (22%) |